St. Jude touts Euro approval for updated CRM implants

Wed, 11/28/2012 - 10:08am
Mass Device

Medical device giant St. Jude Medical lands CE Mark approval in the European Union for upgraded versions of its Assura cardiac rhythm management implants.

St. Jude Medical logo

Medical device company St. Jude Medical (NYSE:STJ) announced CE Mark approval in the European Union for its upgraded suite of Assura ICDs and cardiac resynchronization therapy defibrillators.

The new devices feature a trio of new algorithms that help protect patients against unnecessary shocking while maintaining the "highest amount of delivered energy," according to a press release.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.